Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

50%(1 trials)

Phase Distribution

Ph phase_3

25%

Ph not_applicable

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 3Large-scale testing

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(2)

Detailed Status

Completed2

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (25.0%)

N/A3 (75.0%)

Trials by Status

completed250%

unknown250%

Recent Activity

0 active trials

Showing 4 of 4

unknownnot_applicable

Biofunctionalization of a Volume-stable Collagen Matrix (VCMX) for the Treatment of Single Gingival Recession

NCT05916742

completednot_applicable

Comparison of Two Flaps for Root Coverage

NCT02814279

unknownnot_applicable

Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion.

NCT03594513

completedphase_3

"Clinical Trials to Enhance Elders' Oral Health" ("TEETH")

NCT00004640

Clinical Trials (4)

Showing 4 of 4 trials

NCT05916742Not Applicable

Biofunctionalization of a Volume-stable Collagen Matrix (VCMX) for the Treatment of Single Gingival Recession

Unknown

NCT02814279Not Applicable

Comparison of Two Flaps for Root Coverage

Completed

NCT03594513Not Applicable

Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion.

Unknown

NCT00004640Phase 3

"Clinical Trials to Enhance Elders' Oral Health" ("TEETH")

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4